BIOTIME 8-K OCTOBER 18 2010

Company

Lineage Cell Therapeutics, Inc.

Filed

October 19, 2010

Period of Report

October 18, 2010

Accession Number

0001140361-10-041536

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →